BiotechTube
Home/Arbutus Biopharma/Andrew J. Sung
AJ

Andrew J. Sung

General Counsel

Arbutus Biopharma

Therapeutic Areas

VirologyInfectious DiseasesHepatology

Arbutus Biopharma Pipeline

DrugIndicationPhase
Imdusiran (AB-729)Chronic Hepatitis B Virus (HBV)Phase 2
AB-101Chronic Hepatitis B Virus (HBV)Phase 1/2
AB-161Chronic Hepatitis B Virus (HBV)Phase 1

Leadership Team at Arbutus Biopharma

LA
Lindsay Androski
President & CEO and Chairperson
TN
Tuan Nguyen
Chief Financial Officer
RB
Robert Beardsley
Director
JB
Joseph Bishop
Director
JJ
Jordan J. Feld
Scientific Advisory Board Member
EG
Ed Gane
Scientific Advisory Board Member
HL
Harry L.A. Janssen
Scientific Advisory Board Member
View full Arbutus Biopharma profile